A federal judge’s decision to revoke the FDA’s approval of the abortion pill mifepristone has led some politicians to ask the Biden Administration not to enforce the ruling. Yet NARAL Pro-Choice America President Mini Timmaraju, who’s in close contact with the White House, tells “Conversations on Health Care” that’s not the right move. “I think calls for the FDA not to comply, while you know emotionally satisfying, are not actually helpful in a litigation strategy. And our goal is for the FDA and the DOJ to prevail in this case. The ruling…is riddled with serious disinformation.”
Timmaraju explains how the Supreme Court could hear the case by the end of this week and how this judge’s opinion could have an even bigger impact on the entire health care sector. Her interview with Mark Masselli and Margaret Flinter is online now.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast December 11, 2025 Congress is scrambling to find a solution to the enhanced…
Originally broadcast December 4, 2025 The doctor who once led the Centers for Disease Control…
Leading nutritionist Marion Nestle, Ph.D., has a sobering message as we get ready for Thanksgiving:…
People around the world are living longer and healthier lives because of an innovative idea…
Originally broadcast November 13, 2025 What if health care for moms and babies came with…
Originally broadcast November 6, 2025 Intimate partner violence affects more women in the United States…